Related Experiment Video
Updated: Jun 20, 2026

Affordable Oxygen Microscopy-Assisted Biofabrication of Multicellular Spheroids
Published on: April 6, 2022
Redox-programmed AQ4N-based nanoreactor for hypoxia amplified bio-reductive chemotherapy with chemo-dynamic and
Zhongxiong Fan1, Longlong Yuan2, Fukai Zhu2
1School of Pharmaceutical Sciences, Institute of Materia Medica, Xinjiang University, Urumqi, 830017, China.
None:
Recognition that solid tumors reside within a profoundly hypoxic and oxidoreductase-rich microenvironment has positioned bioreductive prodrugs as a rational strategy for tumor-selective chemotherapy. Among them, the anthraquinone di-N-oxide AQ4N (banoxantrone) carries two hypoxia-sensitive tertiary amine N-oxide "switches" that are sequentially reduced in hypoxic tumor regions to yield the highly cationic DNA-intercalating topoisomerase II poison AQ4. However, its antitumor efficacy remains limited by insufficient tumor accumulation and heterogeneous hypoxia-driven activation. Here, we exploit PtO coordination to construct a carrier-free nanoreactor (APC) via co-assembly of AQ4N, a Pt[IV] prodrug, and chlorin e6 (Ce6). Under near-infrared irradiation, Ce6-mediated photodynamic oxygen consumption further aggravates local hypoxia, thereby promoting the hypoxia-dependent conversion of AQ4N to AQ4 and the bioreduction of Pt[IV] to Pt[II]. The generated Pt[II] catalyzes Fenton-like reactions with endogenous H2O2 to produce hydroxyl radicals, providing chemodynamic damage that cooperates with photodynamic oxidative stress to amplify AQ4 cytotoxicity. Overall, APC potentiates AQ4N-based bioreductive chemotherapy against hypoxic solid tumors, with chemodynamic and photodynamic effects serving as synergistic auxiliary modalities.
More Related Videos
11:04An In-House-Built and Light-Emitting-Diode-Based Photodynamic Therapy Device for Enhancing Verteporfin Cytotoxicity in a 2D Cell Culture Model
Published on: January 13, 2023
09:12Generation and Functional Verification of Hypoxia-Sensitive Chimeric Antigen Receptor-T Cells
Published on: June 14, 2024
Related Concept Videos
Redox Reactions
Redox Reactions
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...